Bio
Has more than 25 years of international management experience in the life sciences industry. Before joining Abingworth in 2005 was Chief Executive of the Abingworth portfolio company, Astex Therapeutics. Was with Astex for more than five years and was instrumental in establishing it as one of the leading UK biotechnology companies. Previously, was Chief Executive of two divisions of the publicly-listed medical technology company, Datascope Corp. Prior to Datascope, held a number of other senior management positions in the US and Europe, including CEO of Thackray Inc and General Manager Baxter UK. At Abingworth, helps identify and create new businesses and provides support for portfolio companies. Current and past board positions include Astex Therapeutics, Fovea, HBI, IMI, PowderMed, Stanmore Implants and XCounter. BSc from Exeter University and an MBA from INSEAD.Career
![]() |
Abingworth LLPAn international investment group dedicated exclusively to the life sciences and healthcare sectorsEmail: [email protected] |